tirzepatide or semiglutide Semaglutide vs Tirzepatide, which is better for you? Tirzepatide vs Semaglutide: Key Differences
Description
Similar content being viewed by others Introduction Tirzepatide is a long-acting glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (GIPRA) and glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA)

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial

These hormones interact with receptors in areas like the pancreas and brain, prompting the pancreas to release more insulin after meals and helping to lower blood sugar levels in people with type 2 diabetes
Though based on a single case of inadvertent pregnancy in a diabetic woman, larger, long-term studies in planned diabetic pregnancies are necessary to validate these findings

Post-marketing safety concerns with secukinumab: a disproportionality analysis of the FDA adverse event reporting system
